Bernstein analyst Eve Burstein maintains $Revvity (RVTY.US)$ with a buy rating, and adjusts the target price from $133 to $145.
According to TipRanks data, the analyst has a success rate of 62.5% and a total average return of 2.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Revvity (RVTY.US)$'s main analysts recently are as follows:
The primary weak point identified for Revvity in the third quarter was the instruments sector, leading to a reduced guidance for the fourth quarter as the trend is expected to persist, according to an analyst.
The company's third-quarter revenue and earnings per share exceeded the consensus, showcasing a varied revenue performance. The firm noted ongoing stability in the pharmaceutical and biotech sectors, although it highlighted that expenditure on instruments is still restricted, with particular constraints observed in the Chinese market.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.